NCT04634929

Brief Summary

The overall aim of the proposed project is to investigate the contribution of changes in neuronal food processing, hypothalamic reactivity and hormonal factors to weight loss after bariatric surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 3, 2020

Completed
15 days until next milestone

First Posted

Study publicly available on registry

November 18, 2020

Completed
13 days until next milestone

Study Start

First participant enrolled

December 1, 2020

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2024

Completed
Last Updated

January 13, 2023

Status Verified

January 1, 2023

Enrollment Period

3 years

First QC Date

November 3, 2020

Last Update Submit

January 12, 2023

Conditions

Keywords

fMRIhormonal satiety signalinghypothalamusweight loss

Outcome Measures

Primary Outcomes (3)

  • Change in Functional magnetic resonance imaging following intravenous glucose infusion.

    Change in responsivity of the hypothalamus (extracted as percent signal change) as the core region of homeostatic control will be assessed after an intravenous glucose infusion (by calculating the area under the curve of hypothalamic responsivity) before and after bariatric surgery or dietary intervention.

    2 weeks before surgery or start of dietary intervention and 2 weeks after surgery or start of dietary intervention.

  • Experimental functional magnetic resonance imaging task (gustatory stimulation).

    Neuronal gustatory processing of food stimuli will be assessed (ingestion of sweet liquids using a gustometer) using a general linear model (comparing brain activation during ingestion of sweet liquids with brain activation during the ingestion of water) and within as well as between groups analyses. Changes in neural gustatory processing of food stimuli will be assessed before and after bariatric surgery or dietary intervention.

    2 weeks before surgery or start of dietary intervention and 2 weeks after surgery or start of dietary intervention.

  • Assessment of glucose-induced changes in peripheral ghrelin using blood samples.

    Blood is collected to measure the concentration of peripheral ghrelin as an indicator of hormonal satiety signaling. Blood samples are collected at the beginning and end of each experimental session to assess the influence of intravenuous infusion of glucose on ghrelin signaling. Blood samples will be analysed using using commercially available kits (enzyme-linked immunosorbent assay).

    15 minutes before and 15 minutes after functional magnetic resonance imaging

Other Outcomes (1)

  • Weight change

    12 months

Study Arms (2)

bariatric surgery participants

participants with obesity planning to undergo bariatric surgery

Procedure: bariatric surgery

conservative diet participants

participants with obesity planning to controlled conservative behavioral weight loss program

Dietary Supplement: conservative diet

Interventions

bariatric surgery

bariatric surgery participants
conservative dietDIETARY_SUPPLEMENT

conservative diet

conservative diet participants

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

healthy participants with obesity

You may qualify if:

  • planning to undergo bariatric surgery
  • planning to take part in a conservative diet

You may not qualify if:

  • inability to undergo fMRI
  • psychiatric disorders
  • metabolic disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Heidelberg

Heidelberg, Germany

RECRUITING

MeSH Terms

Conditions

ObesityWeight Loss

Interventions

Bariatric Surgery

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBody Weight Changes

Intervention Hierarchy (Ancestors)

BariatricsObesity ManagementTherapeuticsSurgical Procedures, Operative

Study Officials

  • Adrian Billeter, PD, MD

    Department of General, Visceral, and Transplantation Surgery, University of Heidelberg

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 3, 2020

First Posted

November 18, 2020

Study Start

December 1, 2020

Primary Completion

December 1, 2023

Study Completion

February 1, 2024

Last Updated

January 13, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

upon reasonable request

Locations